News | November 09, 2012

D3 Completes More Than 30,000 Advanced Treatment Plans, Commissions 100th Linear Accelerator

d3 logo

November 9, 2012 — The team of dosimetrists and physicists at D3 Oncology Solutions (D3), an affiliate of UPMC and UPMC CancerCenter, recently surpassed significant milestones: completing its 30,000th advanced treatment plan and commissioning its 100th linear accelerator.

"These milestones are significant for us because they reflect the continued confidence of our customers in the quality and efficiency of D3's services," said Kathy Lokay, president and CEO of D3.

Richard Lansberry, treatment planning manager, said, "D3 sets the industry standard for advanced treatment planning. Our core capabilities for centralized planning have been extended into the market through our training programs that help dosimetrists and physicists take their planning techniques to the next level of productivity and quality."

The collaborative nature of the training program can also be seen in other D3 services. From peer review to preparation for accreditation, to adoption of new technologies, D3's service model is bringing expertise to practices to enable local staff to confidently use advanced radiation techniques. An example is D3's Facilitated Commissioning product, which allows a local physicist to partner in the commissioning of a new linear accelerator, gaining first-hand experience at a lower cost while utilizing D3's expertise and proprietary tools.    

One of the key drivers of this collaborative commissioning approach was D3's development of their Diamond Dataset — the industry's first comprehensive catalogue of commissioning data from over 50 linear accelerators. By using this database, D3's physicists are able to significantly reduce the amount of data necessary to commission a new unit with no loss in the accuracy of the final beam models.  Results presented at the 2011 American Association of Physicists in Medicine (AAPM) conference confirmed that the Diamond Dataset dose models were within 1 percent of dose models generated from full commissioning data.

For more information:

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init